Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
暂无分享,去创建一个
Sarah Seifert | Yannis Kalaidzidis | Marino Zerial | Marc Bickle | Martin Stöter | Eugenio Fava | Akin Akinc | Giovanni Marsico | Y. Kalaidzidis | M. Stöter | Eugenio Fava | M. Zerial | M. Bickle | A. Akinc | V. Koteliansky | J. Gilleron | A. Zeigerer | W. Querbes | M. Maier | A. Borodovsky | Giovanni Marsico | Undine Schubert | K. Manygoats | S. Seifert | Cordula Andree | Hila Epstein-Barash | Ligang Zhang | K. Fitzgerald | Kevin Fitzgerald | William Querbes | Victor Koteliansky | Anja Zeigerer | Jerome Gilleron | Hila Epstein-Barash | Cordula Andree | Anna Borodovsky | Ligang Zhang | Martin Maier | Undine Schubert | Kevin Manygoats | Akin Akinc
[1] Young Jik Kwon,et al. Efficient and targeted delivery of siRNA in vivo , 2010, The FEBS journal.
[2] C. Alpers,et al. Novel siRNA Delivery System to Target Podocytes In Vivo , 2010, PloS one.
[3] Y. Kalaidzidis,et al. Rab Conversion as a Mechanism of Progression from Early to Late Endosomes , 2005, Cell.
[4] Shubiao Zhang,et al. Non-viral vectors for the mediation of RNAi. , 2012, Bioorganic chemistry.
[5] T. Kirchhausen,et al. Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.
[6] John Maraganore,et al. A status report on RNAi therapeutics , 2010, Silence.
[7] W. Pardridge,et al. Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. , 2009, Molecular pharmaceutics.
[8] Ding Wang,et al. Construction and Characterization of a Lipotes vexillifer Genomic DNA BAC Library , 2007, Zoological science.
[9] K. G. Rajeev,et al. Modulation of thermal stability can enhance the potency of siRNA , 2010, Nucleic acids research.
[10] M. Lindsay,et al. The Tetraspanin CD 63 / lamp 3 Cycles between Endocytic and Secretory Compartments in Human Endothelial Cells , 2000 .
[11] W. Wickner,et al. Excess vacuolar SNAREs drive lysis and Rab bypass fusion , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Metspalu,et al. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo , 2011, Nucleic acids research.
[13] S. Futaki,et al. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[14] Marino Zerial,et al. Identification of the Switch in Early-to-Late Endosome Transition , 2010, Cell.
[15] F. Maxfield,et al. Membrane transport in the endocytic pathway. , 1995, Current opinion in cell biology.
[16] P. Cullis,et al. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.
[17] Boris Klebanov,et al. Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] M. Farrer,et al. In vivo silencing of alpha-synuclein using naked siRNA , 2008, Molecular neurodegeneration.
[19] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[20] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[21] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[22] Shigeo Matsuda,et al. Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** , 2012, Angewandte Chemie.
[23] M. Rosen,et al. Connexin‐specific cell‐to‐cell transfer of short interfering RNA by gap junctions , 2005, The Journal of physiology.
[24] Fanyu Meng,et al. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. , 2011, The Biochemical journal.
[25] Y. Kalaidzidis,et al. Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes , 2009, Nature.
[26] A. Sachs,et al. Quantitative evaluation of siRNA delivery in vivo. , 2010, RNA.
[27] M. Zerial,et al. Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V , 2012, Molecular biology of the cell.
[28] J. Zeman,et al. quantitative evaluation of by , 2010 .
[29] M. Lindsay,et al. The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. , 2000, Molecular biology of the cell.
[30] S. Futaki,et al. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. , 2011, Biomaterials.
[31] J. Burchard,et al. RNA-Induced Silencing Complex-Bound Small Interfering RNA Is a Determinant of RNA Interference-Mediated Gene Silencing in Mice , 2011, Molecular Pharmacology.
[32] K. G. Rajeev,et al. Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] Sarah Seifert,et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo , 2012, Nature.
[34] M. Stoffel,et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.
[35] M. Damha,et al. Oligoribonucleotide synthesis. The silyl-phosphoramidite method. , 1993, Methods in molecular biology.
[36] Y. Nagasaki,et al. Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. , 2009, Biomacromolecules.
[37] G. Hannon,et al. Small RNA sorting: matchmaking for Argonautes , 2011, Nature Reviews Genetics.
[38] L. Palmer,et al. Stabilized plasmid-lipid particles: construction and characterization , 1999, Gene Therapy.
[39] Gert Storm,et al. Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.
[40] H. McMahon,et al. Mechanisms of endocytosis. , 2009, Annual review of biochemistry.
[41] M. Zerial,et al. The Rab5 Effector Rabankyrin-5 Regulates and Coordinates Different Endocytic Mechanisms , 2004, PLoS biology.
[42] U. Greber,et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake , 2002, The Journal of cell biology.
[43] J. Kjems,et al. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity , 2009, Nucleic acids research.
[44] K. G. Rajeev,et al. Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.
[45] T. Park,et al. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[46] N. Svrzikapa,et al. In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR) , 2010, Silence.
[47] B. Schnierle,et al. Selective gene silencing by viral delivery of short hairpin RNA , 2010, Virology Journal.
[48] D. Dykxhoorn,et al. Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.
[49] Robert Langer,et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.
[50] H. Mahmutefendic,et al. Murine Cytomegalovirus Perturbs Endosomal Trafficking of Major Histocompatibility Complex Class I Molecules in the Early Phase of Infection , 2010, Journal of Virology.
[51] S. Futaki,et al. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.